Santen Pharmaceutical Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd. (参天製薬株式会社, 4536), Pharmaceutical. 9 cross-shareholdings, a board of 10 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YDH1, filed 2026-06-18. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31266.327.2460.068.0732.004,318
2023-03-31279.0−14.9421.2−38.6032.004,144
2024-03-31302.026.6435.772.5933.003,744
2025-03-31300.036.3409.3103.9836.003,849
2026-03-31291.637.4423.0114.0438.003,968

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
ONO PHARMACEUTICAL CO., LTD.3,457,4008.70.7
MEDIPAL HOLDINGS CORPORATION373,8001.10.2
Mitsubishi UFJ Financial Group, Inc.194,3400.50.0
SEIKAGAKU CORPORATION415,6000.30.8
VITAL KSK HOLDINGS,INC.128,4740.20.3
OHKI HEALTHCARE HOLDINGS CO.,LTD.49,5090.10.4
HOKUYAKU TAKEYAMA Holdings,Inc.16,2610.00.1

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown